As of April 22, 2025, Y-mAbs Therapeutics (YMAB) has a market cap of $0.19 billion USD. According to our data, Y-mAbs Therapeutics is ranked No.7054 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 22, 2025 | $0.19 B |
-45.07%
|
Dec 31, 2024 | $0.35 B |
14.81%
|
Dec 29, 2023 | $0.31 B |
39.75%
|
Dec 30, 2022 | $0.22 B |
-69.90%
|
Dec 31, 2021 | $0.73 B |
-67.26%
|
Dec 31, 2020 | $2.22 B |
58.43%
|
Dec 31, 2019 | $1.40 B |
53.64%
|
Dec 31, 2018 | $0.91 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() United Therapeutics
UTHR
|
$13.17 B |
22.196 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$95.90 M |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$67.47 M |
0.000 M
|
![]() UK
|
![]() Iovance Biotherapeutics
IOVA
|
$1.05 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$45.10 M |
2.615 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.21 B |
61.524 M
|
![]() France
|
![]() Allogene Therapeutics
ALLO
|
$0.35 B |
7.298 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$39.68 M |
0.193 M
|
![]() USA
|
![]() Autolus Therapeutics
AUTL
|
$0.43 B |
0.000 M
|
![]() UK
|
Market Cap | = | YMAB Stock Price | * | YMAB Shares Outstanding |
= | $4.26 | * | 45.22 M | |
= | $0.19 B |